Voyager Therapeutics Inc Stock
Voyager Therapeutics Inc Stock
The Voyager Therapeutics Inc stock is trending slightly upwards today, with an increase of €0.010 (0.140%) compared to yesterday's price.
Currently there is a rather positive sentiment for Voyager Therapeutics Inc with 3 Buy predictions and 0 Sell predictions.
With a target price of 16 € there is potential for a 113.05% increase which would mean more than doubling the current price of 7.51 € for Voyager Therapeutics Inc.
Our community identified positive and negative aspects for Voyager Therapeutics Inc stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Voyager Therapeutics Inc stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Voyager Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Voyager Therapeutics Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Voyager Therapeutics Inc | 0.140% | 0.133% | -5.535% | -29.151% | -5.535% | 115.433% | - |
Evolus Inc | 2.610% | 2.609% | 0.000% | 44.785% | 30.387% | 26.203% | - |
Ardelyx Inc. | 3.070% | 1.608% | 0.032% | 93.211% | 9.308% | 11.823% | - |
Salarius Pharmaceuticals Inc. | - | -3.015% | -16.087% | -67.833% | -30.450% | -98.515% | -99.994% |
News
Voyager Therapeutics stock pops 30% on deal with Novartis
Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with